UNSPSC 85613124: Supplement pancreatic duct with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pancreatic duct with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUD37Z

UNSPSC 85613124 Supplement pancreatic duct with autologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six opportunities posted between July and September 2026 tagged to this code cover independent medical evaluations for pension disability determinations, surgical center-of-excellence benefits carve-outs, occupational medical surveillance, youth detention healthcare services, pharmacy benefit management administration, and temporary health professional staffing — none of which involve pancreatic duct supplementation or autologous tissue procedures. The mismatch between the code's clinical procedure scope and the actual work being solicited suggests either miscoding in the source records or incidental tagging unrelated to the code's intended application.

The issuing bodies in the sample include city retirement offices, municipal health departments, state transportation authorities, county juvenile probation and human resources departments, and county health systems across Arizona, California, Florida, and Washington. State and local procurement under this code is not supported by the available evidence.